# Pelvic Actinomycosis Related to Intrauterine Device: A Case Report

**Authors:** Mariana Pereira, Susana Peres, Kamal Mansinho

PMC · DOI: 10.7759/cureus.80839 · Cureus · 2025-03-19

## TL;DR

A 71-year-old woman with a retained IUD developed pelvic actinomycosis, a rare infection, which was successfully treated with surgery and long-term antibiotics.

## Contribution

This case highlights the importance of recognizing pelvic actinomycosis as a rare but treatable cause of gynecological symptoms.

## Key findings

- Pelvic actinomycosis was confirmed via surgical biopsy in a patient with a retained IUD.
- Treatment with intravenous and oral antibiotics led to a significant reduction in abscess size.
- Early diagnosis and IUD removal are critical for managing this infection.

## Abstract

Actinomycosis is a rare but persistent bacterial infection caused by Actinomyces spp., a Gram-positive bacillus that typically inhabits the oropharynx and gastrointestinal and urogenital tracts. It can infiltrate deeper tissues following trauma, surgery, or foreign body presence, forming granulomatous masses of filamentous bacilli. While cervicofacial actinomycosis is the most prevalent form, pelvic actinomycosis has been strongly associated with prolonged intrauterine device (IUD) use, where chronic irritation of the endothelium facilitates bacterial invasion. Diagnosing actinomycosis can be challenging due to its slow progression and clinical resemblance to malignancies. This report presents a case of a 71-year-old woman with postmenopausal uterine bleeding, abdominal mass, anemia, and weight loss. Imaging identified a complex pelvic mass, and surgical biopsy confirmed pelvic actinomycosis. The patient was treated with high-dose intravenous penicillin followed by prolonged oral antibiotic therapy. Additionally, a degraded, retained IUD suspected as the infection source was removed. A follow-up MRI showed a significant reduction in abscess size after one year of treatment. An actinomycosis diagnosis is crucial for effective treatment planning, with beta-lactam antibiotics being the cornerstone of therapy. However, severe cases may necessitate surgical drainage or resection. Given its ability to mimic other gynecological conditions, early recognition and appropriate management of pelvic actinomycosis, including prompt IUD removal when indicated, are essential for optimal patient outcomes.

## Linked entities

- **Chemicals:** penicillin (PubChem CID 2349)
- **Diseases:** actinomycosis (MONDO:0005631), anemia (MONDO:0002280)

## Full-text entities

- **Diseases:** bleeding (MESH:D006470), abdominal mass (MESH:D000007), infection (MESH:D007239), trauma (MESH:D014947), anemia (MESH:D000740), Actinomycosis (MESH:D000196), cervicofacial actinomycosis (MESH:D000197), bacterial infection (MESH:D001424), weight loss (MESH:D015431), malignancies (MESH:D009369), abscess (MESH:D000038)
- **Species:** Actinomyces (genus) [taxon 1654], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12007729/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12007729/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12007729/full.md

---
Source: https://tomesphere.com/paper/PMC12007729